Drugs Controller General of India

National Press Release

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

July 21, 2021

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients